Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 receptor agonists have transformed weight management for millions, but women and couples considering pregnancy face important questions about timing and safety. Current evidence suggests semaglutide should be discontinued before attempting conception, though the exact window depends on individual health factors and fertility timelines. PlexusDx helps patients navigate these decisions through personalized medication planning and genetic insights.

Semaglutide Safety During Pregnancy Planning

Semaglutide was not studied in pregnant individuals during clinical trials, which is standard practice for new medications. The FDA currently classifies semaglutide as Pregnancy Category C, meaning animal studies have shown some risk but human data remains limited. Most fertility specialists and obstetric guidelines recommend discontinuing GLP-1 medications at least two to three months before actively trying to conceive, allowing the medication to fully clear your system.

Weight loss achieved before pregnancy often improves fertility outcomes and reduces pregnancy complications like gestational diabetes. Stopping semaglutide doesn't erase the progress you've made—many patients maintain weight loss through sustained lifestyle changes after stopping the medication. Your PlexusDx provider can help time your medication pause to align with your fertility plan and discuss maintenance strategies during this transition period.

How GLP-1 Medications Affect Fertility and Conception

GLP-1 receptor agonists slow stomach emptying and reduce appetite, which can lead to rapid weight loss. Significant weight loss itself may temporarily affect menstrual cycles and ovulation in some individuals, though this typically normalizes once weight stabilizes. If you're experiencing irregular cycles while taking semaglutide, your fertility window may be harder to predict, making conception planning more challenging.

For individuals with PCOS or metabolic conditions causing infertility, the weight loss and improved insulin sensitivity from semaglutide may actually enhance fertility prospects long-term. Stopping the medication after achieving weight loss goals often allows these metabolic improvements to persist. PlexusDx patients can work with their provider to establish the optimal stopping point that maximizes fertility while preserving hard-won weight loss results.

Timing Your Semaglutide Stop for Pregnancy Planning

The standard recommendation is to stop semaglutide two to three months before attempting conception, giving your body time to eliminate the medication completely. This timeline also allows your menstrual cycle to regulate and restabilize, improving your ability to track ovulation accurately. Some patients prefer stopping earlier if they want several months to establish new eating patterns and confirm weight stability before trying to conceive.

Coordinate your medication pause with your OB-GYN or fertility specialist to ensure your plan fits your specific health profile. If you're working with a fertility clinic, they may have additional recommendations based on your ovulation patterns, partner factors, or any underlying fertility diagnoses. PlexusDx providers can synchronize your semaglutide timeline with fertility treatment schedules and help you discuss these plans with your entire care team.

Maintaining Weight Loss After Stopping Semaglutide

Returning to normal appetite after semaglutide requires intentional lifestyle support to prevent rapid weight regain. Behavioral strategies like consistent meal timing, protein intake optimization, and regular movement become the foundation of long-term weight maintenance. Many patients find that the weight lost on semaglutide stays off when they've developed sustainable eating and exercise habits during treatment.

PlexusDx offers personalized guidance on medication-free weight maintenance tailored to your genetic predispositions and metabolic pathways. The Precision Peptide Genetic Test identifies how your body responds to peptide signaling, helping you understand which nutrition and activity approaches will work best for you specifically. This genetic insight supports successful weight maintenance during your fertility journey and beyond, even without ongoing medication.

Compounded Semaglutide From Licensed Pharmacies

PlexusDx partners with licensed 503A compounding pharmacies to provide semaglutide injections starting at $149 per month, with no insurance required and HSA/FSA eligibility. Compounded semaglutide offers the same active ingredient as brand medications, manufactured under strict pharmaceutical standards at a fraction of retail costs. This affordability allows patients to pursue weight management goals before pregnancy without financial strain.

When you're ready to plan your medication timeline around conception, PlexusDx providers work with you to coordinate your treatment duration, stopping point, and transition strategy. Your dose may need to go up during active treatment, but your price won't—maintaining predictable monthly costs from $149 onward. Whether you use semaglutide for three months or several years before conception, you'll have consistent pricing and personalized clinical support throughout your journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need to stop semaglutide immediately if I want to get pregnant?

No—you should plan to stop semaglutide two to three months before attempting conception, not immediately. This timing allows the medication to clear your system and your menstrual cycle to regulate. Coordinate your stop date with your OB-GYN to align with your fertility plan and treatment timeline.

What if I accidentally become pregnant while taking semaglutide?

Contact your OB-GYN or midwife immediately to discuss your situation. While semaglutide is Category C and animal studies haven't shown major birth defects, human pregnancy data is limited. Your healthcare provider will evaluate your individual circumstances and help you make informed decisions about your care.

Will I gain back all my weight after stopping semaglutide?

Weight regain varies widely but often doesn't return to baseline if you've developed lasting lifestyle habits during treatment. Many PlexusDx patients maintain 50–70% of their weight loss after stopping medication. Your Precision Peptide Genetic Test results help identify personalized nutrition and activity approaches that support long-term weight stability.

Can PlexusDx help me plan my medication timeline around pregnancy?

Yes—PlexusDx providers work with you to coordinate when to start, continue, or pause semaglutide based on your fertility goals and timeline. You'll receive guidance on dose adjustment, stopping dates, and transition support. PlexusDx also facilitates communication with your OB-GYN or fertility specialist to ensure coordinated care.

How does the Precision Peptide Genetic Test help with pregnancy planning?

The test maps 14 pathways and 150+ genetic insights related to appetite regulation and metabolism, including variants in GLP1R, GIPR, FTO, and MC4R genes. This information helps you understand your natural metabolic tendencies after stopping medication, supporting personalized strategies for maintaining weight loss during your fertility journey and pregnancy preparation.

Is compounded semaglutide safe for me if I'm planning pregnancy soon?

Compounded semaglutide from licensed 503A pharmacies meets the same safety and purity standards as brand versions. If you're planning to conceive within a few months, discuss with PlexusDx whether a short treatment duration makes sense for your goals, or whether stopping semaglutide now and focusing on maintenance is a better approach.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves